Apellis Pharmaceuticals
APLS
APLS
183 hedge funds and large institutions have $3.83B invested in Apellis Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 72 increasing their positions, 53 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 36
4.44% more ownership
Funds ownership: 79.9% → 84.34% (+4.4%)
3% more funds holding
Funds holding: 178 → 183 (+5)
Holders
183
Holding in Top 10
8
Calls
$40.8M
Puts
$22.3M
Top Buyers
| 1 | +$191M | |
| 2 | +$168M | |
| 3 | +$94.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.8M |
Top Sellers
| 1 | -$42.8M | |
| 2 | -$24.8M | |
| 3 | -$21.8M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$21.3M |
| 5 |
AIIC
AJU IB Investment Company
Seoul,
South Korea
|
-$20.6M |